Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The path to self-management: a qualitative study involving older people with multiple sclerosis.
Cannabinoid pharmacology: the first 66 years.
Time to see the light.
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.
Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.
Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
Studies of EN-1639A (naltrexone): a new narcotic antagonist.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
MULTIPLE SCLEROSIS: MOLECULAR MECHANISMS AND THERAPEUTIC OPPORTUNITIES.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
Update on biomarkers in neuromyelitis optica.
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation.
Management of multiple sclerosis: An overview.
Subcortical atrophy and cognition: Sex effects in multiple sclerosis.
Axonal transport analysis using Multitemporal Association Tracking.
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Pages
« first
‹ previous
…
138
139
140
141
142
143
144
145
146
…
next ›
last »